Importance of cerebrospinal fluid examination in differential diagnosis of Devic’s neuromyelitis optica by multiple sclerosis R. Bergamaschi NEWS AND VIEWS Pages: 95 - 96
CT-guided stereotactic biopsies of brain stem lesions: personal experience and literature review E. J. BoviatsisA. T. KouyialisD. E. Sakas ORIGINAL Pages: 97 - 102
MMPI personality profiles in patients with primary chronic daily headache: a case-control study M. E. BigalF. D. SheftellS. M. Baskin ORIGINAL Pages: 103 - 110
Electromagnetic waves of 900 MHz in acute pentylenetetrazole model in ontogenesis in mice O. O. ErdincM. C. BaykulG. Ozdemir ORIGINAL Pages: 111 - 116
Legal and assistance aspects of Alzheimer’s disease: analysis of 100 cases R. M. RuggieriF. Piccoli ORIGINAL Pages: 125 - 129
Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse E. MilanoA. Di SapioA. Bertolotto CASE REPORT Pages: 130 - 133
Association of spondylocostal dysostosis and type I split cord malformation V. EtusS. CeylanS. Ceylan CASE REPORT Pages: 134 - 137
Creutzfeldt-Jakob disease associated with high titer of antithyroid autoantibodies: case report and literature review G. CossuM. MelisA. Spissu CASE REPORT Pages: 138 - 140
A possible case of unruptured middle cerebral artery aneurysm presenting as epileptic seizures E. ZambrelliA. CavalliniG. Micieli CASE REPORT Pages: 141 - 144
123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy A. AntoniniR. BentiP. Gerundini ORIGINAL Pages: 149 - 150
Brain flow changes before and after deep brain stimulation of the subthalamic nucleus in Parkinson’s disease A. AntoniniG. MarottaS. M. Gaini ORIGINAL Pages: 151 - 152
Cognitve estimation: comparison of two tests in nondemented parkinsonian patients I. M. AppollonioA. RussoL. Frattola ORIGINAL Pages: 153 - 154
Proteome analysis of mesencephalic tissues: evidence for Parkinson’s disease M. BassoS. GiraudoM. Fasano ORIGINAL Pages: 155 - 156
Effects of dopaminergic stimulation on peripheral markers of apoptosis: relevance to Parkinson’s disease F. BlandiniA. MangiagalliG.. Nappi ORIGINAL Pages: 157 - 158
DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism V. BonifatiP. RizzuP. Heutink ORIGINAL Pages: 159 - 160
The diagnostic importance of the isolated supranuclear downward gaze ophthalmoplegia in progressive supranuclear palsy A. BrusaA. R. BentivoglioR. Stoehr ORIGINAL Pages: 161 - 161
Dopaminergic degeneration and perfusional impairment in Lewy body dementia and Alzheimer’s disease R. CeravoloD. VolterraniU. Bonuccelli ORIGINAL Pages: 162 - 163
Presence of β-arrestin in cellular inclusions in metamphetamine-treated PC12 cells A. De BlasiL. CapobiancoA. Picascia ORIGINAL Pages: 164 - 165
Dementia, ataxia, extrapyramidal features, and epilepsy: phenotype spectrum in two Italian families with spinocerebellar ataxia type 17 G. De MicheleF. MalteccaA. Bruni ORIGINAL Pages: 166 - 167
Frequency of familial aggregation in primary adult-onset cranial cervical dystonia G. DefazioM. S. AnielloD. Martino ORIGINAL Pages: 168 - 169
Bedtime cabergoline in Parkinson’s disease patients with excessive daytime sleepiness induced by dopamine agonists P. Del DottoG. GambacciniU. Bonuccelli ORIGINAL Pages: 170 - 171
Decreased plasma and cerebrospinal fluid content of neuroactive steroids in Parkinson’s disease F. di MicheleP. LongoneP. Stanzione ORIGINAL Pages: 172 - 173
Continuous apomorphine infusion and neuropsychiatric disorders: a controlled study in patients with advanced Parkinson’s disease A. E. Di RosaA. EpifanioL. Morgante ORIGINAL Pages: 174 - 175
Natural history and clinical features of progressive supranuclear palsy: a clinical study C. DiromaC. Dell’AquilaG. Iliceto ORIGINAL Pages: 176 - 177
Excessive daytime somnolence in Parkinson’s disease. Follow-up after 1 year of treatment G. FabbriniP. BarbantiG. Meco ORIGINAL Pages: 178 - 179
Neuroprotective effects mediated by dopamine receptor agonists against malonate-induced lesion in the rat striatum R. FancelluM.-T. ArmenteroF. Blandini ORIGINAL Pages: 180 - 181
Amphetamines induce ubiquitin-positive inclusions within striatal cells F. FornaiG. LazzeriA. Paparelli ORIGINAL Pages: 182 - 183
Deficit of short-term memory in newly diagnosed untreated parkinsonian patients: reversal after L-dopa therapy P. MariniS. RamatM. Paganini ORIGINAL Pages: 184 - 185
Progressive supranuclear palsy: analysis of six cases M. MarraV. ToniG. Coppola ORIGINAL Pages: 186 - 187
Neuroacanthocytosis: clinical, radiological, and neurophysiological findings in an Italian family A. M. MarsonE. BucciantiniC. Geda ORIGINAL Pages: 188 - 189
Psychometric properties of the Unified Parkinson’s Disease Rating Scale and of the Short Parkinson’s Evaluation Scale E. MartignoniF. FranchignoniD. Picco ORIGINAL Pages: 190 - 191
Levodopa pharmacokinetics and dyskinesias: are there sex-related differences? P. MartinelliM. ContinA. Baruzzi ORIGINAL Pages: 192 - 193
Six years’ experience in deep brain stimulation in Parkinson’s disease: advantages and limitations of use of neurophysiological intraoperative microreading G. P. NorderaT. MesianoV. Toso ORIGINAL Pages: 194 - 194
Sleep attacks in Parkinson’s disease: a clinical and polysomnographic study C. PacchettiE. MartignoniR. Manni ORIGINAL Pages: 195 - 196
The use of entacapone in patients with advanced Parkinson’s disease: 2 years’ experience C. PaciS. SanguigniL. Curatola ORIGINAL Pages: 197 - 198
Cerebrospinal fluid biochemical markers in early detection and in differential diagnosis of dementia disorders in routine clinical practice L. ParnettiA. LanariV. Gallai ORIGINAL Pages: 199 - 200
A paradoxical acute effect of levodopa in de novo parkinsonian patients: worsening of some bradykinetic components C. PasettiM. M. LualdiP. Pinelli ORIGINAL Pages: 201 - 202
Hedonistic homeostatic dysregulation in Parkinson’s disease: a short screening questionnaire F. R. PezzellaS. Di RezzeG. Meco ORIGINAL Pages: 205 - 206
Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment L. PrianoG. AlbaniA. Mauro ORIGINAL Pages: 207 - 208
Health-Related Quality of Life and sleep disorders in Parkinson’s disease T. ScaravilliE. GasparoliF. Bracco ORIGINAL Pages: 209 - 210
Progressive dysarthria: definition and clinical follow-up P. SoliveriS. PiacentiniF. Girotti ORIGINAL Pages: 211 - 212
Distal-proximal differences in limb apraxia in corticobasal degeneration but not progressive supranuclear palsy P. SoliveriS. PiacentiniF. Girotti ORIGINAL Pages: 213 - 214
Italian Huntington disease patients-data and tissue bank F. SquitieriM. CannellaF. Pierelli ORIGINAL Pages: 215 - 216
Optimizing levodopa pharmacokinetics in Parkinson’s disease: the role of COMT inhibitor F. StocchiL. VaccaS. Ruggieri ORIGINAL Pages: 217 - 218
Acute akinesia or akinetic crisis in Parkinson’s disease A. ThomasD. IaconoM. Onofrj ORIGINAL Pages: 219 - 220
Use of antiparkinsonian drugs in the Umbria Region N. VanacoreC. BianchiM. Rossi ORIGINAL Pages: 221 - 222
Association of tau gene polymorphism with Parkinson’s disease M. ZappiaG. AnnesiA. Quattrone ORIGINAL Pages: 223 - 224
